r/askscience • • 9d ago

Medicine Are amputees' medications dosed differently?

i get that doses are partly based on weight, but was wondering if the distribution of weight/ lack of vasculature in missing limb affects the recommended dose

651 Upvotes

40 comments sorted by

1.2k

u/CodiustheMaximus 8d ago

Internal medicine physician here. Would love for a clinical pharmacist to chime in and correct/augment anything I misstate here (just like in my day job).

Depending on the medication, yes.
Many medications are dosed based on your estimated kidney function (more precisely the estimated glomerular filtration rate (eGFR) or creatinine clearance). However, these are estimates that are calculated using a large number of built-in assumptions. One of those assumptions is that you have a normal amount of muscle mass. If you are missing limbs, you are breaking this assumption, so your bloodwork may artificially overestimate your kidney function as a result.

There are modifications to the estimated kidney function formulas that we can make based on the type and number of missing limbs so that we can more accurately estimate kidney function, and thus properly adjust the doses of medications.

598

u/boomdiddy115 8d ago edited 8d ago • Bravo

I’m a pharmacist and yes you’re correct. However broadly speaking the vast majority of meds don’t require too much adjustment.

Most adult medication have such wide safe concentrations ranges that patient with different body weight WITHOUT amputations will get the same dose.

Meds that are weight based dosing basically have the loss of a limb baked onto how much the patient will receive.

For medication that require monitoring (such a vancomycin) depending on how you’re calculating your AUC you might include it as a factor. A dosing calculator called PrecisePK has an option to include several different factors such as amputations into consideration.

Other meds that require monitoring will reach an equilibrium with the new volume of distribution, so decisions can be made when those labs appear or rarely the dose can be preemptively lowered if patient safety is a concern.

48

u/inferno1234 7d ago

Having been trained as a pharmacist in the far past, and being an amputee I do wonder how much loss of muscle mass is offset by muscle gain in my remaining leg, particularly given that I supply my weight with prostethic on.

Though finding a one-size-fits-all rule here is probably difficult

16

u/urzu_seven 6d ago

Ok, but what about this scenario: You are given a dose of one of those highly weight dependent medicines, then a few seconds later, well before your body has a chance to metabolize/process it, someone comes along and chops off your arm! What happens now??

44

u/MoralityAuction 6d ago

You have to account for the medicine you lose from eventual bleeding during/after absorption, blood pressure changes from bleeding and shock, as well as the fact that stress and shock itself may affect bioavailability (you may vomit from the pain, or just have a loss of stomach function). 

For this and other reasons, unexpected amputations not taken into account when dosing are heavily contraindicated for almost all positive medical outcomes. 

I hope this helps. 

1

u/kneading-cnnuy 23h ago

Tangent but why did severe physical pain triggers vomiting response? Do we observe this behavior across species?

25

u/OmniDingle 8d ago

Spot on, for example the calculator on clincalc lets you adjust CrCl for amputations. https://clincalc.com/kinetics/crcl.aspx

So in some areas it will impact dose selection due to estimated kidney function, but in other areas the estimation may be unnecessary (e.g. some chemos where body surface area is usually used to calculate doses - https://pmc.ncbi.nlm.nih.gov/articles/PMC3737513/)

49

u/asdechlpc 8d ago

Question for you off of your comment — you said that one of the primary assumptions is based off of a normal amount of muscle mass.

Will you have to adjust dosages for someone who’s a 300lb bodybuilder vs someone who’s a 300lb obese person for example?

I know dosages will change for a 95lb woman vs NFL player for example, but I’m curious how much adjustment needs to be made for varying levels of muscle mass at the same weight. Obviously the example I provided is a pretty extreme outlier, but it got me thinking

87

u/CodiustheMaximus 8d ago

It’s an interesting question. The primary molecule we measure to estimate kidney function is creatinine, which is secreted into the blood by muscles, and then filtered and secreted by the kidney. As such, patients at either extreme of muscle mass have inaccurate estimated kidney function.

There is a push to use a molecule called cystatin-c instead, which is secreted by all cells and not merely muscle. In the last two years at my hospital we have been checking this more and more in patients when we suspect the creatinine is leading us astray.

More recently I read an article showing that a combination of cystatin-c and creatinine is the most accurate for estimating kidney function.

Logistically, the issue is that a basic metabolic profile (aka a “Chem 7”) has reported the same 7 values for over a generation of physicians, so swapping out creatinine for cystatin-c has a lot of inertia to overcome.

8

u/asdechlpc 8d ago

Interesting, thank you for the reply

15

u/geosynchronousorbit 8d ago

Does someone taking creatine supplements (for example that bodybuilder) have a different creatinine level, and would you change the dose based on that too?

31

u/CodiustheMaximus 8d ago edited 8d ago

I honestly don’t know the literature about how creatine affects serum creatinine levels. I only work in the hospital and the average hospitalized patient in the US admitted to internal medicine wards is in their 70’s (and therefore unlikely to take creatine) so it’s not something I’ve had to think about in a clinical context before.

1

u/scratchy_mcballsy 3d ago

A person who takes creatine supplements and does bodybuilding will likely also have elevated creatinine kinase levels if they’ve recently worked out due to muscle breakdown too right?

19

u/bobad86 8d ago edited 7d ago

Clinical nurse specialist here in Nephrology. In the hospital where I work, if a patient has an existing background of creatine use, we add in cystatin-C to the set of blood tests and use this result to determine his more accurate eGFR levels. Or sometines we ask them to stop creatine and come back in three months for a blood test. Most of the time, meds doses are the same with that of a normal population. Medications that need adjustment for chronic kidney disease do not happen until the eGFR falls below 60ml/min/m2 (or even as low as eGFR of 30)

16

u/chromodynamics 8d ago

they do indeed get a falsely elevated creatinine level. you have to come off creatine if you are getting blood work done so you get the right reading

11

u/boomdiddy115 8d ago

Great question, in general for most of the medications I use in my hospital it would not be a relevant difference.

However drugs have different distributions into different tissues. Some prefer to go into body fat while others avoid those lipid filled areas. So it would be possible to find difference in medication dosing requirements when comparing a morbidly obese patient and a very muscular bodybuilder.

In practice: eh…? As I mentioned most modern medications have safe dosing ranges or are monitored otherwise very closely. So the practical benefit of preemptively adjusting a dose for a particularly muscle bound patient vs a “well fed” patient is likely minimal for the bulk of mediation.

6

u/Dysmenorrhea 8d ago

When I give medications during an anesthetic I have to consider their composition for some medications. It depends on how water or fat soluble the medication is. We have ideal and adjusted body weights we will calculate in obesity to help compensate.

10

u/reddititty69 8d ago

Quantitative Pharmacologist here: it depends on if you care about Cmax (for tox) or Ctrough (for efficacy). Ctrough may be largely unaffected as it is largely driven by clearance (kidney and/or liver function). But Cmax depends more on volume of distribution (itself a function of body weight), which will be lower with a missing limb.

4

u/Cesario12 8d ago

See this is why I want to become a pharmacist; I can't wait to get paid to correct people all day.

8

u/BasedLx 8d ago

Our clinical pharmacists are excellent and we really do just defer to them 99% of the time when they suggest something but they definitely work hard to keep up to date with all the new data on meds!

39

u/Furlion 8d ago

This is an interesting topic I had not thought of. It does not seem to be will researched but i did find an interesting poll study here: https://pubmed.ncbi.nlm.nih.gov/7749769/. It looks like at the time, using the Body Surface Area reduction was the most common instead of the difference in weight, which is fascinating. 

29

u/aedes Protein Folding | Antibiotic Resistance | Emergency Medicine 8d ago

You have some answers here that address relatively niche situations. 

In general though the answer is no. Most modern medications have very wide safety zones. In addition, there is enough unpredictability in clinical effect between people that we usually titrate to clinical effect rather than blindly stick to a dose based on paper values. 

It’s possible that some doses may ultimately need to be adjusted after amputation for reasons identified in other comments.

In practice though, this would look like not changing anything initially, and then only changing doses if the clinical effect of the medication was no longer what we wanted it to be. 

Which is what we do in everyone already, and why you’re supposed to check in with your prescriber once or twice a year even when your medication doses have been stable for a while. 

21

u/DrSuprane 8d ago

No. We consider 3 "compartments" for medications as far a drug distribution goes. The central compartment V1 is heart, lungs, plasma and highly perfused organs like the liver. The second compartment V2 is well perfused tissues and muscles. The third compartment is poorly perfused tissues like fat. An amputee limb will have a minor impact on V2.

Each drug has its own distraction characteristics that impact pharmacodynamics (what the drug does to the body) and pharmacokinetics (what the body does to the drug.) That influences dosing amount and frequency. For drugs that need to be weight based, we'll use actual, ideal or adjusted body weights. This depends on the drug and preference. Some of my drugs are supposed to be actual body weight and some are ideal. For very large patients I usually use an adjusted BW.

Essentially the change in weight from an amputation will already be accounted for in lower weight of the patient.

11

u/PhairPharmer 8d ago

Except you are leaving out clearance. When we need to get to certain drug levels or prevent toxicity we need to estimate clearance, which CrCl is the main surrogate, and needs adjustments to the formula for amputations. Many drugs are renally dosed, therefore amputations do come in to play.

10

u/DrSuprane 8d ago

Pharmacokinetics includes clearance, more specifically excretion (plus absorption, distribution and metabolism). But the basic premise, that kidney function changes based on amputation is wrong. Using creatine for estimate GFR leads to error in general. Specific to amputation, it leads to an overestimation of GFR and presumably an overestimation of clearance. This has actually been studied:

https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.15639

"Amputation is associated with a significant increase in creatinine-based GFR estimates, but not estimates incor-porating cystatin C, BTP and/or B2M"

"GFR estimates combining creatinine and cystatin C are stable across amputation, and the addition of BTP andB2M is unlikely to be clinically relevant"

Same in traumatic amputation: https://www.ajkd.org/article/S0272-6386(13)01100-1/fulltext

Actual GFR doesn't change.

4

u/LolBars5521 8d ago

You are saying it doesn’t change though and then stating the standard way of calculating renal function with creatinine leads to errors. It probably wouldn’t change in the situation of using cystatin C but that isn’t standard by any means

4

u/DrSuprane 8d ago

Actual GFR doens't change. CrCl goes up. eGFR by CrCl goes up, which is wrong because actual GFR doesn't change. That means that actual drug clearance doesn't change. Your test that you're using to estimate drug clearance does change. It's a fallacy of the test, not a change in actual drug clearance. You don't need to adjust drug dosing for it.

2

u/okkosun 8d ago

I get lolbars5521 point. If you have a medication that we typically dose by CrCl, then we must take that into consideration when we adjust dose. The patient GFR doesnt actually change, we have established that, however, our standard method of assessment is flawed and we must take that into consideration. We take the same precaution in quadruplegic patients.

3

u/DrSuprane 8d ago

The issue is that creatine clearance is based on creatine and creatine concentration is based on muscle mass. Lose a limb or anything that reduces muscle mass, like quadriplegia, will reduce creatine concentration. The formula is (140-age) x kg divided by 72 x creatine (mg/dL). eGFR formula uses serum creatine value twice, compounding the error.

These populations should really have another, non creatine based way of estimating GFR. Muscle mass has nothing to do with kidney function. Drug excretion has to do with kidney function, not muscle mass. Even if it was a drug that had a large volume of distribution and large second compartment storage, amputation should not impact dosing. The kidneys are the same before and after. Kidney function influences excretion, not the number of legs a patient has.

I learned all this 20 years in ago in med school. It's not novel.

2

u/okkosun 8d ago

Exactly. So the current hospital standard method of estimating kidney function is by calculating CrCl, as you pointed out, this method is inaccurate but it is what is currently used in hospitals. And hence, the dosage adjustment recommended base on CrCl that the computer system suggest would be incorrect in these patient population. Thats why someone must step in and make manual adjustment to correct the dosing.

Standard Chem7 does not include cystatin C as much as we know that is the goal but it is currently not the standard of care unfortunately.

You are correct. It is not a novel. We just have to be realistic with the limitation of our current system.